Skip to main content
Top
Published in: BMC Complementary Medicine and Therapies 1/2020

01-12-2020 | Research article

Toxicology studies of aqueous-alcohol extracts of Harpagophytum procumbens subsp. procumbens (Burch.) DC.Ex Meisn. (Pedaliaceae) in female and male rats

Authors: Kirtan Joshi, Alan Parrish, Elizabeth A. Grunz-Borgmann, Mary Gerkovich, William R. Folk

Published in: BMC Complementary Medicine and Therapies | Issue 1/2020

Login to get access

Abstract

Background

A variety of medicinal products prepared from secondary tubers of Harpagophytum procumbens subsp. procumbens (Burch.) DC.ex Meisn. (Devil’s Claw) and H. zeyheri are marketed in Africa, Europe, the United States, South America and elsewhere, where they are used for inflammatory and musculoskeletal conditions such as arthritis, lower back pain, rheumatism and neuralgia, etc. While clinical studies conducted over the last twenty years support the general safety of such products, infrequent gastrointestinal disturbances (diarrhea, nausea, vomiting, abdominal pain), headache, vertigo and hypersensitivity (allergic) reactions (rash, hives and face swelling) have been documented. Sex-related differences occur in the health conditions for which Devil’s Claw products are used, so it is likely that usage is similarly sex-related and so might be side effects and potential toxicities. However toxicologic studies of Devil’s Claw products have been conducted primarily with male animals. To address this deficit, we report toxicological studies in female and male rats of several H. procumbens (HP) aqueous-alcohol extracts chemically analyzed by UPLC-MS.

Methods

Female and male Sprague Dawley rats were studied for one and three months in groups differing by consumption of diets without and with HP extracts at a 7–10-fold human equivalent dose (HED). Sera were analyzed for blood chemistry, and heart, liver, lung, kidney, stomach, and small and large intestine tissues were examined for histopathology. Treatment group differences for blood chemistry were analyzed by ANOVA with Dunnett’s test and significant group differences for endpoints with marginal distributional properties were verified using the Kruskal-Wallis test. Group differences for histopathology were tested using Chi Square analysis.

Results

Significant group by sex-related differences in blood chemistry were detected in both studies. Additionally, several sex-related differences occurred between the studies. However, significant histopathology effects associated with the consumption of the extracts were not detected.

Conclusion

Toxicologic analysis of Devil’s Claw extracts cause significant sex-related effects in blood chemistry. However, in our judgement, none of the observed effects suggest serious toxicity at these doses and durations. Subsequent toxicologic and clinical studies of H. procumbens and other medicines with similar properties should explore in greater detail the basis and consequences of potential sex-related effects.
Appendix
Available only for authorised users
Literature
2.
go back to reference Mncwangi N, et al. Devil's claw-a review of the ethnobotany, phytochemistry and biological activity of Harpagophytum procumbens. J Ethnopharmacol. 2012;143(3):755–71.CrossRef Mncwangi N, et al. Devil's claw-a review of the ethnobotany, phytochemistry and biological activity of Harpagophytum procumbens. J Ethnopharmacol. 2012;143(3):755–71.CrossRef
3.
go back to reference Mncwangi NP, et al. What the devil is in your phytomedicine? Exploring species substitution in Harpagophytum through chemometric modeling of 1H-NMR and UHPLC-MS datasets. Phytochemistry. 2014;106:104–15.CrossRef Mncwangi NP, et al. What the devil is in your phytomedicine? Exploring species substitution in Harpagophytum through chemometric modeling of 1H-NMR and UHPLC-MS datasets. Phytochemistry. 2014;106:104–15.CrossRef
4.
go back to reference Oltean H, et al. Herbal medicine for low-back pain. Cochrane Database Syst Rev. 2014;12:CD004504. Oltean H, et al. Herbal medicine for low-back pain. Cochrane Database Syst Rev. 2014;12:CD004504.
5.
go back to reference Gagnier JJ, et al. Herbal medicine for low Back pain: a Cochrane review. Spine (Phila Pa 1976). 2016;41(2):116–33.CrossRef Gagnier JJ, et al. Herbal medicine for low Back pain: a Cochrane review. Spine (Phila Pa 1976). 2016;41(2):116–33.CrossRef
6.
go back to reference Marriott I, Huet-Hudson YM. Sexual dimorphism in innate immune responses to infectious organisms. Immunol Res. 2006;34(3):177–92.CrossRef Marriott I, Huet-Hudson YM. Sexual dimorphism in innate immune responses to infectious organisms. Immunol Res. 2006;34(3):177–92.CrossRef
7.
go back to reference Straub RH. The complex role of estrogens in inflammation. Endocr Rev. 2007;28(5):521–74.CrossRef Straub RH. The complex role of estrogens in inflammation. Endocr Rev. 2007;28(5):521–74.CrossRef
8.
go back to reference Cutolo M, et al. The immunomodulatory effects of estrogens: clinical relevance in immune-mediated rheumatic diseases. Ann N Y Acad Sci. 2010;1193:36–42.CrossRef Cutolo M, et al. The immunomodulatory effects of estrogens: clinical relevance in immune-mediated rheumatic diseases. Ann N Y Acad Sci. 2010;1193:36–42.CrossRef
9.
go back to reference Blagojevic M, et al. Risk factors for onset of osteoarthritis of the knee in older adults: a systematic review and meta-analysis. Osteoarthr Cartil. 2010;18(1):24–33.CrossRef Blagojevic M, et al. Risk factors for onset of osteoarthritis of the knee in older adults: a systematic review and meta-analysis. Osteoarthr Cartil. 2010;18(1):24–33.CrossRef
10.
go back to reference Pereira D, et al. The effect of osteoarthritis definition on prevalence and incidence estimates: a systematic review. Osteoarthr Cartil. 2011;19(11):1270–85.CrossRef Pereira D, et al. The effect of osteoarthritis definition on prevalence and incidence estimates: a systematic review. Osteoarthr Cartil. 2011;19(11):1270–85.CrossRef
11.
go back to reference Srikanth VK, et al. A meta-analysis of sex differences prevalence, incidence and severity of osteoarthritis. Osteoarthr Cartil. 2005;13(9):769–81.CrossRef Srikanth VK, et al. A meta-analysis of sex differences prevalence, incidence and severity of osteoarthritis. Osteoarthr Cartil. 2005;13(9):769–81.CrossRef
12.
go back to reference Felson DT, Zhang Y. An update on the epidemiology of knee and hip osteoarthritis with a view to prevention. Arthritis Rheum. 1998;41(8):1343–55.CrossRef Felson DT, Zhang Y. An update on the epidemiology of knee and hip osteoarthritis with a view to prevention. Arthritis Rheum. 1998;41(8):1343–55.CrossRef
13.
go back to reference Felson DT, et al. The incidence and natural history of knee osteoarthritis in the elderly. The Framingham Osteoarthritis Study. Arthritis Rheum. 1995;38(10):1500–5.CrossRef Felson DT, et al. The incidence and natural history of knee osteoarthritis in the elderly. The Framingham Osteoarthritis Study. Arthritis Rheum. 1995;38(10):1500–5.CrossRef
14.
go back to reference Lawrence RC, et al. Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States. Arthritis Rheum. 1998;41(5):778–99.CrossRef Lawrence RC, et al. Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States. Arthritis Rheum. 1998;41(5):778–99.CrossRef
15.
go back to reference Schiphof D, et al. Factors for pain in patients with different grades of knee osteoarthritis. Arthritis Care Res (Hoboken). 2013;65(5):695–702.CrossRef Schiphof D, et al. Factors for pain in patients with different grades of knee osteoarthritis. Arthritis Care Res (Hoboken). 2013;65(5):695–702.CrossRef
16.
go back to reference Boyan BD, et al. Hormonal modulation of connective tissue homeostasis and sex differences in risk for osteoarthritis of the knee. Biol Sex Differ. 2013;4(1):3.CrossRef Boyan BD, et al. Hormonal modulation of connective tissue homeostasis and sex differences in risk for osteoarthritis of the knee. Biol Sex Differ. 2013;4(1):3.CrossRef
17.
go back to reference Karsdal MA, et al. The pathogenesis of osteoarthritis involves bone, cartilage and synovial inflammation: may estrogen be a magic bullet? Menopause Int. 2012;18(4):139–46.CrossRef Karsdal MA, et al. The pathogenesis of osteoarthritis involves bone, cartilage and synovial inflammation: may estrogen be a magic bullet? Menopause Int. 2012;18(4):139–46.CrossRef
18.
go back to reference Pfeilschifter J, et al. Changes in proinflammatory cytokine activity after menopause. Endocr Rev. 2002;23(1):90–119.CrossRef Pfeilschifter J, et al. Changes in proinflammatory cytokine activity after menopause. Endocr Rev. 2002;23(1):90–119.CrossRef
19.
go back to reference Razmjou S, et al. Effect of the menopausal transition and physical activity energy expenditure on inflammatory markers: a MONET group study. Menopause. 2016;23(12):1330–8.CrossRef Razmjou S, et al. Effect of the menopausal transition and physical activity energy expenditure on inflammatory markers: a MONET group study. Menopause. 2016;23(12):1330–8.CrossRef
20.
go back to reference Guo R, et al. Botany, Phytochemistry, pharmacology and toxicity of Strychnos nux-vomica L.: a review. Am J Chin Med. 2018;46(1):1–23.CrossRef Guo R, et al. Botany, Phytochemistry, pharmacology and toxicity of Strychnos nux-vomica L.: a review. Am J Chin Med. 2018;46(1):1–23.CrossRef
21.
go back to reference Vlachojannis J, Roufogalis BD, Chrubasik S. Systematic review on the safety of Harpagophytum preparations for osteoarthritic and low back pain. Phytother Res. 2008;22(2):149–52.CrossRef Vlachojannis J, Roufogalis BD, Chrubasik S. Systematic review on the safety of Harpagophytum preparations for osteoarthritic and low back pain. Phytother Res. 2008;22(2):149–52.CrossRef
22.
go back to reference Devil's claw root: ulcers and gastrointestinal bleeding? Prescrire Int. 2013;22(144):296. Devil's claw root: ulcers and gastrointestinal bleeding? Prescrire Int. 2013;22(144):296.
23.
go back to reference Cuspidi C, et al. Systemic hypertension induced by Harpagophytum procumbens (devil's claw): a case report. J Clin Hypertens (Greenwich). 2015;17(11):908–10.CrossRef Cuspidi C, et al. Systemic hypertension induced by Harpagophytum procumbens (devil's claw): a case report. J Clin Hypertens (Greenwich). 2015;17(11):908–10.CrossRef
24.
go back to reference Posadzki P, Watson LK, Ernst E. Adverse effects of herbal medicines: an overview of systematic reviews. Clin Med (Lond). 2013;13(1):7–12.CrossRef Posadzki P, Watson LK, Ernst E. Adverse effects of herbal medicines: an overview of systematic reviews. Clin Med (Lond). 2013;13(1):7–12.CrossRef
25.
go back to reference Carvalho RR, et al. Syndrome of inappropriate antidiuretic hormone secretion induced by the phytotherapy Harpagophytum procumbers: case report. J Bras Nefrol. 2017;39(1):79–81.CrossRef Carvalho RR, et al. Syndrome of inappropriate antidiuretic hormone secretion induced by the phytotherapy Harpagophytum procumbers: case report. J Bras Nefrol. 2017;39(1):79–81.CrossRef
26.
go back to reference Newall CA, Anderson LA, Phillipson JD. Herbal medicines : a guide for health-care professionals. 1996. London: Pharmaceutical Press. Newall CA, Anderson LA, Phillipson JD. Herbal medicines : a guide for health-care professionals. 1996. London: Pharmaceutical Press.
27.
go back to reference Shaw D, et al. Traditional remedies and food supplements. A 5-year toxicological study (1991-1995). Drug Saf. 1997;17(5):342–56.CrossRef Shaw D, et al. Traditional remedies and food supplements. A 5-year toxicological study (1991-1995). Drug Saf. 1997;17(5):342–56.CrossRef
28.
go back to reference Whitehouse LW, Znamirowska M, Paul CJ. Devil's claw (Harpagophytum procumbens): no evidence for anti-inflammatory activity in the treatment of arthritic disease. Can Med Assoc J. 1983;129(3):249–51.PubMedPubMedCentral Whitehouse LW, Znamirowska M, Paul CJ. Devil's claw (Harpagophytum procumbens): no evidence for anti-inflammatory activity in the treatment of arthritic disease. Can Med Assoc J. 1983;129(3):249–51.PubMedPubMedCentral
29.
go back to reference Al-Harbi NO. Toxicity studies on Harpagophytum procumbens (Devil's claw) capsules in mice. J Med Plants Res. 2013;7(42):3089–97. Al-Harbi NO. Toxicity studies on Harpagophytum procumbens (Devil's claw) capsules in mice. J Med Plants Res. 2013;7(42):3089–97.
30.
go back to reference Davari SA, Miri A, Shahraki E. Teratogenic effects of Harpagophytum procumbens Ethanolic extract in mice and fetuses. Zahedan J Res Med Sci. 2016;18(10):e3481. Davari SA, Miri A, Shahraki E. Teratogenic effects of Harpagophytum procumbens Ethanolic extract in mice and fetuses. Zahedan J Res Med Sci. 2016;18(10):e3481.
31.
go back to reference Ungerer, G.C., J; Ndam, ; Bekemeier, M; Song, H; Li, R; Siedhold, H; Yang, B; Appenteng, M; Greenlief, M, Miller D; Sun, G; Folk, W; Gu, Z, Harpagophytum procumbens extract ameliorates allodynia and modulates oxidative and antioxidant stress pathways in a rat model of spinal cord injury. Neuromolecular Medicine, 2020. In press. Ungerer, G.C., J; Ndam, ; Bekemeier, M; Song, H; Li, R; Siedhold, H; Yang, B; Appenteng, M; Greenlief, M, Miller D; Sun, G; Folk, W; Gu, Z, Harpagophytum procumbens extract ameliorates allodynia and modulates oxidative and antioxidant stress pathways in a rat model of spinal cord injury. Neuromolecular Medicine, 2020. In press.
32.
go back to reference Parenti C, et al. Involvement of the Heme-Oxygenase pathway in the Antiallodynic and Antihyperalgesic activity of Harpagophytum procumbens in rats. Molecules. 2015;20(9):16758–69.CrossRef Parenti C, et al. Involvement of the Heme-Oxygenase pathway in the Antiallodynic and Antihyperalgesic activity of Harpagophytum procumbens in rats. Molecules. 2015;20(9):16758–69.CrossRef
33.
go back to reference in Relieving Pain in America: A Blueprint for Transforming Prevention, Care, Education, and Research. 2011: Washington (DC). in Relieving Pain in America: A Blueprint for Transforming Prevention, Care, Education, and Research. 2011: Washington (DC).
34.
go back to reference Kim S, Joo KW. Electrolyte and acid-base disturbances associated with non-steroidal anti-inflammatory drugs. Electrolyte Blood Press. 2007;5(2):116–25.CrossRef Kim S, Joo KW. Electrolyte and acid-base disturbances associated with non-steroidal anti-inflammatory drugs. Electrolyte Blood Press. 2007;5(2):116–25.CrossRef
35.
go back to reference Schmeltzer PA, et al. Liver injury from nonsteroidal anti-inflammatory drugs in the United States. Liver Int. 2016;36(4):603–9.CrossRef Schmeltzer PA, et al. Liver injury from nonsteroidal anti-inflammatory drugs in the United States. Liver Int. 2016;36(4):603–9.CrossRef
36.
go back to reference Knights KM, Mangoni AA, Miners JO. Non-selective nonsteroidal anti-inflammatory drugs and cardiovascular events: is aldosterone the silent partner in crime? Br J Clin Pharmacol. 2006;61(6):738–40.CrossRef Knights KM, Mangoni AA, Miners JO. Non-selective nonsteroidal anti-inflammatory drugs and cardiovascular events: is aldosterone the silent partner in crime? Br J Clin Pharmacol. 2006;61(6):738–40.CrossRef
37.
go back to reference Solomon DH, et al. Derivation and validation of a major toxicity risk score among nonsteroidal Antiinflammatory drug users based on data from a randomized controlled trial. Arthritis Rheumatol. 2019;71(8):1225–31.CrossRef Solomon DH, et al. Derivation and validation of a major toxicity risk score among nonsteroidal Antiinflammatory drug users based on data from a randomized controlled trial. Arthritis Rheumatol. 2019;71(8):1225–31.CrossRef
38.
go back to reference Anauate MC, Torres LM, de Mello SB. Effect of isolated fractions of Harpagophytum procumbens D.C. (devil's claw) on COX-1, COX-2 activity and nitric oxide production on whole-blood assay. Phytother Res. 2010;24(9):1365–9.CrossRef Anauate MC, Torres LM, de Mello SB. Effect of isolated fractions of Harpagophytum procumbens D.C. (devil's claw) on COX-1, COX-2 activity and nitric oxide production on whole-blood assay. Phytother Res. 2010;24(9):1365–9.CrossRef
Metadata
Title
Toxicology studies of aqueous-alcohol extracts of Harpagophytum procumbens subsp. procumbens (Burch.) DC.Ex Meisn. (Pedaliaceae) in female and male rats
Authors
Kirtan Joshi
Alan Parrish
Elizabeth A. Grunz-Borgmann
Mary Gerkovich
William R. Folk
Publication date
01-12-2020
Publisher
BioMed Central
Published in
BMC Complementary Medicine and Therapies / Issue 1/2020
Electronic ISSN: 2662-7671
DOI
https://doi.org/10.1186/s12906-019-2789-9

Other articles of this Issue 1/2020

BMC Complementary Medicine and Therapies 1/2020 Go to the issue